Controlling Antimicrobial Resistance through Targeted, Vaccine-Induced Replacement of Strains

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Tekle, Yonas I ^a,g   Nielsen, Kaare M ^b,c   Liu, Jingzhou ^a   Pettigrew, Melinda M ^a   Meyers, Lauren A ^e,f   Galvani, Alison P ^a   Townsend, Jeffrey P ^a,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TROMSØ   (Norway)

^c Research Park   (Norway)

^d YALE UNIVERSITY   (United States)

^e UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^f SANTA FE INSTITUTE   (United States)

^g SPELMAN COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; STAPHYLOCOCCUS VACCINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DRUG TARGETING; EPIDEMIC; FEASIBILITY STUDY; GENOTYPE; HOSPITAL INFECTION; INFECTION PREVENTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROORGANISM; PUBLIC HEALTH; SEROTYPE; STATISTICAL MODEL; VACCINATION;

ANTI-INFECTIVE AGENTS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; GENOTYPE; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL VACCINES; VACCINATION;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 84870804215     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050688     Document Type: Article

References (48)

1. Scott JA, Hall AJ, Dagan R, Dixon JM, Eykyn SJ, et al. (1996) Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease. Clin Infect Dis 22: 973-981.
2. Feikin DR, Klugman KP, (2002) Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines. Clin Infect Dis 35: 547-555.
3. Robbins JB, Austrian R, Lee CJ, Rastogi SC, Schiffman G, et al. (1983) Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis 148: 1136-1159.
4. Urwin G, Krohn JA, Deaver-Robinson K, Wenger JD, Farley MM, (1996) Invasive disease due to Haemophilus influenzae serotype f: clinical and epidemiologic characteristics in the H. influenzae serotype b vaccine era. The Haemophilus influenzae Study Group. Clin Infect Dis 22: 1069-1076.
5. Ribeiro GS, Reis JN, Cordeiro SM, Lima JB, Gouveia EL, et al. (2003) Prevention of Haemophilus influenzae type b (Hib) meningitis and emergence of serotype replacement with type a strains after introduction of Hib immunization in Brazil. J Infect Dis 187: 109-116.
6. Spratt BG, Greenwood BM, (2000) Prevention of pneumococcal disease by vaccination: does serotype replacement matter? Lancet 356: 1210-1211.
7. Gonzalez BE, Hulten KG, Lamberth L, Kaplan SL, Mason EO Jr, (2006) Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine. Pediatr Infect Dis J 25: 301-305.
8. McEllistrem MC, Adams J, Mason EO, Wald ER, (2003) Epidemiology of acute otitis media caused by Streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine. J Infect Dis 188: 1679-1684.
9. Perez-Trallero E, Vicente D, Montes M, Cisterna R, (2002) Positive effect of meningococcal C vaccination on serogroup replacement in Neisseria meningitidis. Lancet 360: 953.
10. Hallander HO, Advani A, Donnelly D, Gustafsson L, Carlsson RM, (2005) Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs. J Clin Microbiol 43: 2856-2865.
11. Lowy FD, (1998) Medical progress- Staphylococcus aureus infections. New England Journal of Medicine 339: 520-532.
12. Klein E, Smith DL, Laxminarayan R, (2007) Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis 13: 1840-1846.
13. Colley EW, Mcnicol MW, Bracken PM (1965) Methicillin-Resistant Staphylococci in a General Hospital. Lancet 1: 595
14. Saravolatz LD, Markowitz N, Arking L, Pohlod D, Fisher E, (1982) Methicillin-Resistant Staphylococcus-Aureus- Epidemiologic Observations during a Community-Acquired Outbreak. Annals of Internal Medicine 96: 11-16.
15. Bancroft EA, (2007) Antimicrobial resistance - It's not just for hospitals. Jama-Journal of the American Medical Association 298: 1803-1804.
16. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, et al. (2002) The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proceedings of the National Academy of Sciences of the United States of America 99: 7687-7692.
17. Schaffer AC, Lee JC, (2009) Staphylococcal vaccines and immunotherapies. Infect Dis Clin North Am 23: 153-171.
18. McCarthy NL, Sullivan PS, Gaynes R, Rimland D, (2010) Health care-associated and community-associated methicillin-resistant Staphylococcus aureus infections: A comparison of definitions. Am J Infect Control 38: 600-606.
19. Spellberg B, Daum R (2011) Development of a vaccine against Staphylococcus aureus. Semin Immunopathol.
20. Bagnoli F, Bertholet S, Grandi G (2012) Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials Frontiers in Cellular and Infection Microbiology.
21. Bagnoli F, Baudner B, Mishra RP, Bartolini E, Fiaschi L, et al. (2011) Designing the next generation of vaccines for global public health. OMICS 15: 545-566.
22. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, et al. (2003) Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. Jama-Journal of the American Medical Association 290: 2976-2984.
23. Fey PD, Said-Salim B, Rupp ME, Hinrichs SH, Boxrud DJ, et al. (2003) Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 47: 196-203.
24. Boyce JM, (1998) Are the epidemiology and microbiology of methicillin-resistant Staphylococcus aureus changing? Jama-Journal of the American Medical Association 279: 623-624.
25. Chambers HF, (2001) The changing epidemiology of Staphylococcus aureus? Emerging Infectious Diseases 7: 178-182.
26. Robinson DA, Enright MC, (2003) Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 47: 3926-3934.
27. Willems RJ, Hanage WP, Bessen DE, Feil EJ, (2011) Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance. FEMS Microbiol Rev 35: 872-900.
28. Webb GF, Horn MA, D'Agata EM, Moellering RC, Ruan S, (2009) Competition of hospital-acquired and community-acquired methicillin-resistant Staphylococcus aureus strains in hospitals. J Biol Dyn 48: 271-284.
29. Dall'Antonia M, Coen PG, Wilks M, Whiley A, Millar M, (2005) Competition between methicillin-sensitive and-resistant Staphylococcus aureus in the anterior nares. Journal of Hospital Infection 61: 62-67.
30. Cespedes C, Said-Salim B, Miller M, Lo SH, Kreiswirth BN, et al. (2005) The clonality of Staphylococcus aureus nasal carriage. J Infect Dis 191: 444-452.
31. D'Agata EM, Webb GF, Pressley J, (2010) Rapid Emergence of Co-colonization with Community-acquired and Hospital-Acquired Methicillin-Resistant Staphylococcus aureus Strains in the Hospital Setting. Math Model Nat Phenom 5: 76-73.
32. Khatib R, Sharma M, Naqvi SA, Riederer K, Almoujahed MO, et al. (2003) Molecular analysis of Staphylococcus aureus blood isolates shows lack of polyclonal bacteremia. J Clin Microbiol 41: 1717-1719.
33. D'Agata EM, Webb GF, Horn MA, Moellering RC Jr, Ruan S, (2009) Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals. Clin Infect Dis 48: 274-284.
34. Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, et al. (2001) Efficacy of a pneumococcal conjugate vaccine against acute otitis media. New England Journal of Medicine 344: 403-409.
35. Shinefield HR, Black S, (2000) Efficacy of pneumococcal conjugate vaccines in large scale field trials. Pediatric Infectious Disease Journal 19: 394-397.
36. Grundmann H, Aanensen DM, van den Wijngaard CC, Spratt BG, Harmsen D, et al. (2010) Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis. PLoS Med 7: e1000215.
37. Okuma K, Iwakawa K, Turnidge JD, Grubb WB, Bell JM, et al. (2002) Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. Journal of Clinical Microbiology 40: 4289-4294.
38. Iannelli M, Martcheva M, Li XZ, (2005) Strain replacement in an epidemic model with super-infection and perfect vaccination. Mathematical Biosciences 195: 23-46.
39. Lipsitch M, (1999) Bacterial vaccines and serotype replacement: Lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae. Emerging Infectious Diseases 5: 336-345.
40. Tarzi S, Kennedy P, Stone S, Evans M, (2001) Methicillin-resistant Staphylococcus aureus: psychological impact of hospitalization and isolation in an older adult population. Journal of Hospital Infection 49: 250-254.
41. Catalano G, Houston SH, Catalano MC, Butera AS, Jennings SM, et al. (2003) Anxiety and depression in hospitalized patients in resistant organism isolation. Southern Medical Journal 96: 141-145.
42. Stelfox HT, Bates DW, Redelmeier DA, (2003) Safety of patients isolated for infection control. Jama-Journal of the American Medical Association 290: 1899-1905.
43. Varrone JJ, Li D, Daiss JL, Schwarz EM, (2011) Anti-Glucosaminidase Monoclonal Antibodies as a Passive Immunization for Methicillin-Resistant Staphylococcus aureus (MRSA) Orthopaedic Infections. Bonekey Osteovision 8: 187-194.
44. Kajita E, Okano JT, Bodine EN, Layne SP, Blower S, (2007) Modelling an outbreak of an emerging pathogen. Nat Rev Microbiol 5: 700-709.
45. Lipsitch M, (2001) Interpreting results from trials of pneumococcal conjugate vaccines: a statistical test for detecting vaccine-induced increases in carriage of nonvaccine serotypes. Am J Epidemiol 154: 85-92.
46. Lipsitch M, (1999) Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae. Emerg Infect Dis 5: 336-345.
47. Bahl J, Vijaykrishna D, Holmes EC, Smith GJ, Guan Y, (2009) Gene flow and competitive exclusion of avian influenza A virus in natural reservoir hosts. Virology 390: 289-297.
48. Feng Z, Velasco-Hernandez JX, (1997) Competitive exclusion in a vector-host model for the dengue fever. J Math Biol 35: 523-544.